RE: Also23 Oct 2018 14:42
TF, I did say 10x "for starters". I'd probably settle for that, take out a bit of cash for the pension fund!
When you consider all the trials past/present/future, the trial and pre-clinical data to date, the 3 (possibly more?) platforms, the changing sentiment toward immuno-oncology AND factoring in risks, fund-raising, dilution etc - this could easily be a 20 bagger.
Not saying, tomorrow, next week or anytime soon but 20x - easy! IMHO, DYOR